XERS
Xeris Biopharma Holdings
$8.21
−$0.11 (−1.32%)Jul 27, 2026
Key metrics
The numbers that frame XERS today
- Market cap
- $1.42B
- P/E (TTM)
- 118.0
- EV / FCF
- 32.9
- Gross margin
- 85.9%
- EV / Sales
- 5.0
- ROIC
- 13%
- Div yield
- 0%
- Debt / equity
- 19.9
- 52wk Low
- $4.87
- 52wk High
- $10.08
Growth
Revenue and earnings trend for XERS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XERS
Is Xeris Biopharma Holdings a good buy?
Yes. Xeris Biopharma Holdings has strong quality and strong momentum. Both signals support the setup. Growth looks strong, which supports the long-term business case. We think Xeris Biopharma Holdings is selling at a fair price.
What is the market capitalization of XERS?
Xeris Biopharma Holdings's market capitalization is $1.42B.
What is the P/E ratio for XERS stock?
Xeris Biopharma Holdings's current P/E ratio is 118.
What is the 52-week high for XERS stock?
The 52-week high for Xeris Biopharma Holdings is $10.08. The current close of $8.21 is 18.6% below that high.
What is the 52-week low for XERS stock?
The 52-week low for Xeris Biopharma Holdings is $4.87. The current close of $8.21 is 68.6% above that low.
Does XERS stock pay dividends?
Xeris Biopharma Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XERS?
Xeris Biopharma Holdings's Debt / Equity ratio is 19.87.